Citation Impact
Citing Papers
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
2011 Standout
Application of the Electrotopological State Index to QSAR Analysis of Flavone Derivatives as HIV-1 Integrase Inhibitors
1996 StandoutNobel
Herpes Simplex Viruses
1998
Isolation of Human Immunodeficiency Virus from Genital Ulcers in Nairobi Prostitutes
1989
Valacyclovir for the Suppression of Recurrent Genital Herpes in Human Immunodeficiency Virus–Infected Subjects
2003
Herpes simplex virus infections
2001
Marine natural products
1990 Standout
Herpes Simplex Virus Type 2 in the United States, 1976 to 1994
1997
Genital Infection of Female Chimpanzees with Human Immunodeficiency Virus Type 1
1998 StandoutNobel
Aciclovir
1994
Phylogenetic Analysis of SIV and STLV Type I in Mandrills ( Mandrillus sphinx ): Indications That Intracolony Transmissions Are Predominantly the Result of Male-to-Male Aggressive Contacts
1998 StandoutNobel
Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds
1994 StandoutNobel
Once-daily valacyclovir hydrochloride for suppression of recurrent genital herpes
1999 StandoutNobel
Cytotoxicity, antiviral and antimicrobial activities of alkaloids, flavonoids, and phenolic acids
2011 Standout
Ab Initio Modeling of the Herpesvirus VP26 Core Domain Assessed by CryoEM Density
2006 StandoutNobel
Genital Herpes and Public Health
2000
Serological Testing for Herpes Simplex Virus (HSV)–1 and HSV‐2 Infection
2002
Present Status and Future Prospects for HIV Therapies
1993 Science
Herpes Simplex Virus (HSV) Type 2 Glycoprotein D Subunit Vaccines and Protection against Genital HSV‐1 or HSV‐2 Disease in Guinea Pigs
2003
Chloropeptins, New Anti-HIV Antibiotics Inhibiting gp120-CD4 Binding from Streptomyces sp. I. Taxonomy, Fermentation, Isolation, and Physico-chemical Properties and Biological Activities.
1997 StandoutNobel
Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol
2006 Standout
Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies
2005 Standout
Sexually transmitted diseases treatment guidelines
2003 Standout
Once-Daily Valacyclovir to Reduce the Risk of Transmission of Genital Herpes
2003
Male Circumcision for the Prevention of HSV-2 and HPV Infections and Syphilis
2009 Standout
Pharmaceutical and therapeutic Potentials of essential oils and their individual volatile constituents: a review
2007 Standout
Isochromophilones I and II, Novel Inhibitors against gpl20-CD4 Binding Produced by Penicillium multicolor FO-2338. I. Screening, Taxonomy, Fermentation, Isolation and Biological Activity.
1995 StandoutNobel
Oral Famciclovir for the Suppression of Recurrent Genital Herpes<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
1998
A comprehensive review in current developments of benzothiazole-based molecules in medicinal chemistry
2014 Standout
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Oral Famciclovir for Suppression of Recurrent Genital Herpes Simplex Virus Infection in Women
1997
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
2009 Standout
Genital Herpes Simplex Virus Infections: Current Concepts in Diagnosis, Therapy, and Prevention
1983
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Recurrences after Oral and Genital Herpes Simplex Virus Infection
1987
Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine
2020 StandoutNobel
Long-term Acyclovir Suppression of Frequently Recurring Genital Herpes Simplex Virus Infection
1988
Varicella-zoster virus
1996 Standout
Herpes Simplex Viruses
2002
Antiviral activity of a sulfoquinovosyldiacylglycerol (SQDG) compound isolated from the green alga Caulerpa racemosa
2007
The Purine Path to Chemotherapy (Nobel Lecture)
1989 Nobel
From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection
1999 Standout
An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection
2020 StandoutNobel
Neonatal herpes infection: diagnosis, treatment and prevention
2002
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
The global and regional burden of genital ulcer disease due to herpes simplex virus: a natural history modelling study
2020
Antiviral cytotoxic T lymphocytes in vaginal mucosa of simian immunodeficiency virus-infected rhesus macaques
1995
Incidence Trends for Human Papillomavirus–Related and –Unrelated Oral Squamous Cell Carcinomas in the United States
2008 Standout
A trivalent subunit antigen glycoprotein vaccine as immunotherapy for genital herpes in the guinea pig genital infection model
2017
Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group.
1997
Antigen-presenting liposomes are effective in treatment of recurrent herpes simplex virus genitalis in guinea pigs
1989
Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes
2019 StandoutNobel
Recurrence Rates in Genital Herpes after Symptomatic First-Episode Infection
1994
Antibodies to Crucial Epitopes on HSV-2 Glycoprotein D as a Guide to Dosing an mRNA Genital Herpes Vaccine
2022 StandoutNobel
Works of A. Fahnlander being referenced
Transmission of Genital Herpes in Couples with One Symptomatic and One Asymptomatic Partner: A Prospective Study
1988
Secretory IgA Antibody in Cervicovaginal Secretions from Women with Genital Infection Due to Herpes Simplex Virus
1984
Double-blind controlled trial of topical acyclovir in genital herpes simplex virus infections
1982
Transmission of Genital Herpes in Couples With One Symptomatic and One Asymptomatic Partner: A Prospective Study
1989
A Double-Blind Study of Oral Acyclovir for Suppression of Recurrences of Genital Herpes Simplex Virus Infection
1984
Treatment of primary first-episode genital herpes simplex virus infections with acyclovir: results of topical, intravenous and oral therapy
1983
A Double-Blind Study of Oral Acyclovir for Suppression of Recurrences of Genital Herpes Simplex Virus Infection
1984